Skip to main content

Table 4 Crude and adjusted OR and 95% CI general and respiratory complications

From: Ten-year experience with standardized non-operating room anesthesia with Sevoflurane for MRI in children affected by neuropsychiatric disorders

 

General complication development

Respiratory complications development

OR

95% CI

p

Adj. OR

95% CI

p

OR

95% CI

p

Adj. OR

95% CI

p

ASA score > 1

2.19

1.29–3.73

0.003

2.22

1.30–3.77

0.003

2.75

1.38–5.48

0.003

2.34

1.19–4.73

0.017

Age (months)

1.01

1.00–1.01

0.061

1.03

0.97–1.08

0.281

1.01

1.0–1.01

0.086

1.06

0.98–1.13

0.099

Weight (Kg)

1.01

0.99–1.02

0.506

   

1.00

0.98–1.03

0.855

   

Male sex

1.71

1.05–2.78

0.028

1.73

1.07–2.81

0.025

1.86

0.95–3.81

0.065

1.86

0.94–3.71

0.074

Neuromuscular diseases

1.49

0.58–3.82

0.409

   

3.27

1.24–8.68

0.012

3.18

1.20–8.41

0.020

Premedication

1.07

0.60–1.90

0.821

   

0.85

0.40–1.79

0.658

   

Multi-pharmacological anesthesia

2.87

1.24–6.64

0.010

2.98

1.26–7.06

0.013

–

–

–

–

–

–

Non sevofluorane-based anesthesia

1.80

0.90–3.60

0.094

   

0.98

0.30–3.22

0.969

   

Anesthesia length > 50 min

1.73

1.02–2.91

0.039

1.62

0.96–2.73

0.068

2.12

0.97–4.61

0.053

1.91

0.89–4.10

0.097

Season autumn-winter

1.28

0.82–1.98

0.276

   

1.99

1.05–3.76

0.031

2.01

1.06–3.78

0.030

  1. IQR Inter-quartile range; OR Odds ratio; Adj. OR Adjusted odds ratio;
  2. CI Confidence interval
  3. The level of statistical significance at 0.05 is set in bold